8 May 2026 | 9:00 - 15:00 (Cyprus time) | The Landmark Nicosia, Cyprus

Europe stands at a critical moment for its life sciences sector.

Across the world, governments are actively strengthening their biotechnology ecosystems through investment, faster regulatory systems and targeted industrial strategies.

Europe has the scientific excellence, research infrastructure and industrial capabilities to lead the next generation of medical innovation. But leadership is not guaranteed.

The choices Europe makes today — particularly through initiatives such as the EU Biotech Act, the Life Sciences Strategy and the Strategic Dialogue on Pharmaceuticals — will determine whether Europe will remain globally competitive and whether patients will benefit from the next wave of innovation.

This event will bring together policymakers, industry leaders, researchers and patient representatives to explore how Europe can unlock the full potential of biotechnology for patients, the economy, and Europe’s long-term security.

Register here.

(Confirmed) Speakers:

• Neophytos Charalambides, Minister of Health of Cyprus
• Michael Damianos, Minister of Energy, Commerce and Industry of Cyprus
• MEP Michalis Hadjipantela, Member of the SANT Committee and former Minister of Health of Cyprus
• Olga Solomon, Head of Unit ‘Medicines: policy, authorization, and monitoring’ of the European Commission
• Padraic Ward, Head of Pharma International at Roche
• Marianna Prokopi-Demetriades, Biotech innovator and co-founder of Theramir, Promed, and RSL
• Leonidas A. Phylactou, CEO and Medical Director at the Cyprus Institute of Neurology & Genetics
• Spyros Polyviou, Member of the Board of the Cyprus Federation of Patients’ Associations (CyFPA) and Director of the Cyprus Alliance for Rare Disorders
• Iphigenia Kammitsi, Director General at the Cyprus Health Insurance Organisation
• Otello Stampacchia, Managing Director at Omega Funds
• Kyriakos Mikellis, KEFEA President
• Nathalie Moll, EFPIA Director General
• Thomas Allvin, EFPIA Executive Director for Strategy and Healthcare Systems